Literature DB >> 23822047

How IRB leaders view and approach challenges raised by industry-funded research.

Robert Klitzman1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23822047      PMCID： PMC3792492     

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  15 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Protecting the health of the public--Institute of Medicine recommendations on drug safety.

Authors:  Bruce M Psaty; Sheila P Burke
Journal:  N Engl J Med       Date:  2006-10-09       Impact factor: 91.245

3.  Time to nip "seeding trials" in the bud.

Authors:  Kenneth A Katz
Journal:  Arch Dermatol       Date:  2008-03

4.  Reforming the regulations governing research with human subjects.

Authors:  Ezekiel J Emanuel; Jerry Menikoff
Journal:  N Engl J Med       Date:  2011-07-25       Impact factor: 91.245

5.  Institutional review board community members: who are they, what do they do, and whom do they represent?

Authors:  Robert Klitzman
Journal:  Acad Med       Date:  2012-07       Impact factor: 6.893

6.  Views and experiences of IRBs concerning research integrity.

Authors:  Robert Klitzman
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

7.  False hopes and best data: consent to research and the therapeutic misconception.

Authors:  P S Appelbaum; L H Roth; C W Lidz; P Benson; W Winslade
Journal:  Hastings Cent Rep       Date:  1987-04       Impact factor: 2.683

8.  Community hospital oversight of clinical investigators' financial relationships.

Authors:  Mark A Hall; Kevin P Weinfurt; Janice S Lawlor; Joëlle Y Friedman; Kevin A Schulman; Jeremy Sugarman
Journal:  IRB       Date:  2009 Jan-Feb

9.  How local IRBs view central IRBs in the US.

Authors:  Robert Klitzman
Journal:  BMC Med Ethics       Date:  2011-06-23       Impact factor: 2.652

10.  The ethics police?: IRBs' views concerning their power.

Authors:  Robert Klitzman
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240
View more
  3 in total

1.  Barriers to Effective Deliberation in Clinical Research Oversight.

Authors:  Danielle M Wenner
Journal:  HEC Forum       Date:  2016-09

2.  How IRBs view and make decisions about social risks.

Authors:  Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2013-07       Impact factor: 1.742

3.  Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest.

Authors:  Eric M Meslin; Joshua B Rager; Peter H Schwartz; Kimberly A Quaid; Margaret M Gaffney; Jon Duke; William H Tierney
Journal:  Clin Transl Med       Date:  2015-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.